Informationen:
Fehler:
ID
20213
Beschreibung
A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy; ODM derived from: https://clinicaltrials.gov/show/NCT00506207
Link
https://clinicaltrials.gov/show/NCT00506207
Stichworte
Versionen (1)
- 13.02.17 13.02.17 -
Hochgeladen am
13. Februar 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Colorectal Neoplasm NCT00506207
Eligibility Colorectal Neoplasm NCT00506207
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Colorectal Neoplasm NCT00506207
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Colorectal Carcinoma unresectable | Colorectal Carcinoma metastatic | Stomach Carcinoma unresectable | Stomach Carcinoma metastatic
Item
histologically or cytologically confirmed unresectable or metastatic colorectal or gastric carcinoma
boolean
C0009402 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C0009402 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C0699791 (UMLS CUI [3,1])
C1519810 (UMLS CUI [3,2])
C0699791 (UMLS CUI [4,1])
C1522484 (UMLS CUI [4,2])
C1519810 (UMLS CUI [1,2])
C0009402 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C0699791 (UMLS CUI [3,1])
C1519810 (UMLS CUI [3,2])
C0699791 (UMLS CUI [4,1])
C1522484 (UMLS CUI [4,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Measurable Disease | Disease Non-Measurable Measurable lesion
Item
measurable disease, according to the recist criteria or non-measurable disease measurable lesions
boolean
C1513041 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C1518373 (UMLS CUI [2,2])
C1513041 (UMLS CUI [2,3])
C0012634 (UMLS CUI [2,1])
C1518373 (UMLS CUI [2,2])
C1513041 (UMLS CUI [2,3])
Adjuvant Chemotherapy Palliative | Fluorouracil | oxaliplatin | irinotecan | Molecular Targeted Therapy | Therapeutic radiology procedure
Item
previous adjuvant, palliative chemotherapy including 5-fu, oxaliplatin and irinotecan, molecular targeted therapy and/or radiotherapy is allowed
boolean
C0085533 (UMLS CUI [1,1])
C1285530 (UMLS CUI [1,2])
C0016360 (UMLS CUI [2])
C0069717 (UMLS CUI [3])
C0123931 (UMLS CUI [4])
C2699893 (UMLS CUI [5])
C1522449 (UMLS CUI [6])
C1285530 (UMLS CUI [1,2])
C0016360 (UMLS CUI [2])
C0069717 (UMLS CUI [3])
C0123931 (UMLS CUI [4])
C2699893 (UMLS CUI [5])
C1522449 (UMLS CUI [6])
Organ function Major
Item
adequate major organ functions
boolean
C0678852 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,2])
Informed Consent
Item
patients should sign a written informed consent before study entry
boolean
C0021430 (UMLS CUI [1])
Peripheral Neuropathy
Item
prior history of peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
Abnormal cardiovascular function
Item
inadequate cardiovascular
boolean
C0232090 (UMLS CUI [1])
Communicable Disease Serious | Illness Non-Malignant
Item
serious concurrent infection or nonmalignant illness
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0221423 (UMLS CUI [2,1])
C1518371 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])
C0221423 (UMLS CUI [2,1])
C1518371 (UMLS CUI [2,2])
Malignant Neoplasms | Skin carcinoma | Carcinoma in situ of uterine cervix
Item
other malignancy within the past 3 years except non-melanomatous skin cancer or carcinoma in situ of the cervix
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
C0699893 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
Mental disorder Compliance behavior Excluded
Item
psychiatric disorder that would preclude compliance
boolean
C0004936 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
C1321605 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
Pregnancy | Breast Feeding | Females & males of reproductive potential Without Contraceptive methods
Item
pregnant, nursing women or patients with reproductive potential without contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C4034483 (UMLS CUI [3,1])
C0332288 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
C0006147 (UMLS CUI [2])
C4034483 (UMLS CUI [3,1])
C0332288 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
Pharmaceutical Preparations Interaction S-1 | Flucytosine | Phenytoin | Warfarin
Item
patients receiving a concomitant treatment with drugs interacting with s-1 such as flucytosine, phenytoin, or warfarin et al.
boolean
C0013227 (UMLS CUI [1,1])
C0687133 (UMLS CUI [1,2])
C0879262 (UMLS CUI [1,3])
C0016278 (UMLS CUI [2])
C0031507 (UMLS CUI [3])
C0043031 (UMLS CUI [4])
C0687133 (UMLS CUI [1,2])
C0879262 (UMLS CUI [1,3])
C0016278 (UMLS CUI [2])
C0031507 (UMLS CUI [3])
C0043031 (UMLS CUI [4])